Synergistic cell death by EGCG and ibuprofen in DU-145 prostate cancer cell line

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 3947-3956

  Kim, Myoung H ^a   Chung, Jaegwon ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Apoptosis; Ceramide; EGCG; Ibuprofen; Prostate cancer

Indexed keywords

ACETYLCYSTEINE; BCL2 RELATED PROTEIN A1; CASPASE; CERAMIDE; EPIGALLOCATECHIN GALLATE; FUMONISIN B1; IBUPROFEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CASPASES; CATECHIN; CELL LINE, TUMOR; CERAMIDES; DRUG SYNERGISM; ENZYME ACTIVATION; HUMANS; IBUPROFEN; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 37549046357     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1999.
2. American Cancer Society: Cancer Facts and Figures, 2007.
3. Kuroda Y and Hara Y: Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat Res 436: 69-97, 1999.
4. Cao Y and Cao R: Angiogenesis inhibited by drinking tea. Nature 398: 381, 1999.
5. Adhami VM, Ahmad N and Mukhtar H: Molecular targets for green tea in prostate cancer prevention. J Nutr 133: 2417S-2424S, 2003.
6. Gupta S, Afaq F and Mukhtar H: Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 21: 3727-3738, 2002.
7. Gupta S, Ahmad N, Nieminen AL and Mukhtar H: Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen- sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 164: 82-90, 2000.
8. Sabichi AL, Demierre MF, Hawk ET, Lerman CE and Lippman SM: Frontiers in cancer prevention research. Cancer Res 63: 5649-5655, 2003.
9. Sabichi AL and Lippman SM: COX-2 inhibitors and other NSAIDs in bladder and prostate cancer. Prog Exp Tumor Res 37: 163-178, 2003.
10. Norrish AE, Jackson RT and McRae CU: Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer 77: 511-515, 1998.
11. Andrews J, Djakiew D, Krygier S and Andrews P: Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells. Cancer Chemother Pharmacol 50: 277-284, 2002.
12. Palayoor ST, Bump EA, Calderwood SK, Bartol S and Coleman CN: Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. Clin Cancer Res 4: 763-771, 1998.
13. Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002.
14. Ko JK, Lee MJ, Cho SH, Cho JA, Lee BY, Koh JS, Lee SS, Shim YH and Kim CW: Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death. Oncogene 22: 2457-2465, 2003.
15. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
16. Chen C, Shen G, Hebbar V, Hu R, Owuor ED and Kong AN: Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24: 1369-1378, 2003.
17. Qanungo S, Das M, Haldar S and Basu A: Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 26: 958-967, 2005.
18. Lavrentiadou SN, Chan C, Kawcak T, Ravid T, Tsaba A, van der Vliet A, Rasooly R and Goldkorn T: Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione. Am J Respir Cell Mol Biol 25: 676-684, 2001.
19. Goldkorn T, Ravid T and Khan EM: Life and death decisions: ceramide generation and EGF receptor trafficking are modulated by oxidative stress. Antioxid Redox Signal 7: 119-128, 2005.
20. Ogretmen B and Hannun YA: Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4: 604-616, 2004.
21. Darzynkiewicz Z, Bedner E and Li X: Analysis of cell death by flow and laser-scanning cytometry. In: Apoptosis, G.P. Studzinski (ed.), 1st edition, New York: Oxford University Press, pp. 57-80, 1999.
22. Liu X, Elojeimy S, El-Zawahry AM, Holman DH, Bielawska A, Bielawski J, Rubinchik S, Guo GW, Dong JY, Keane T, Hannun YA, Tavassoli M and Norris JS: Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer. Mol Ther 14: 637-646, 2006.
23. Sumitomo M, Ohba M, Asakuma J, Asano T, Kuroki T and Hayakawa M: Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J Clin Invest 109: 827-836, 2002.
24. Desai K, Sullards MC, Allegood J, Wang E, Schmelz EM, Hartl M, Humpf HU, Liotta DC, Peng Q and Merrill AH Jr: Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. Biochim Biophys Acta 1585: 188-192, 2002.
25. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV and Gudkov AV: A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737, 1999.
26. Sternberg CN: What's new in the treatment of advanced prostate cancer? Eur J Cancer 39: 136-146, 2003.
27. Gupta S, Hastak K, Ahmad N, Lewin JS and Mukhtar H: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98: 10350-10355, 2001.
28. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN and Price BD: Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18: 7389-7394, 1999.
29. Lin HY, Shih A, Davis FB, Tang HY, Martino LJ, Bennett JA and Davis PJ: Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J Urol 168: 748-755, 2002.
30. Choi SS, Park IC, Yun JW, Sung YC, Hong SI and Shin HS: A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693-1698, 1995.
31. Zong WX, Edelstein LC, Chen C, Bash J and Gelinas C: The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev 13: 382-387, 1999.
32. Long LH, Clement MV and Halliwell B: Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. Biochem Biophys Res Commun 273: 50-53, 2000.